PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
PURE BIOSCIENCE, INC.
Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026
$0.07−0.01 (-12.10%)
Close on Oct 19, 2026
- Market cap
- $7.33M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Pure Bioscience has not reported a dividend
No dividend per share appears in Pure Bioscience's annual filings since fiscal 2010.